Genetically instrumented LDL-cholesterol lowering and multiple disease outcomes: a Mendelian randomisation phenome-wide association study in the UK Biobank.
Kitty PhamAnwar MulugetaAmanda L LumsdenElina HyppӧnenPublished in: British journal of clinical pharmacology (2023)
We found genetic evidence to support both positive and negative effects of LDL-C lowering through all four LDL-C-lowering pathways. Future studies should further explore the effects of LDL-C lowering on lung function and changes in brain volume.